Whats sold today as MOTS-c rests on claims derived from mouse and cell studies, and the FDA had already flagged it for immune-reaction risk
7-1515, Apr
This occurs through targeting virus-containing tubules constituted by viral nonstructural protein Pns11 to sperm surface via Pns11-Pelo interaction
This is the pattern I keep running into in practice: clinical demand outpaces the systems meant to govern it, and the clinicians closest to patients are left interpreting ambiguity in real time, with no monograph, no FDA-approved product, and often no clear precedent, while still being accountable for the outcome
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no
BPC-157s mechanism of action is multifaceted and not fully characterised in all tissue contexts